this post was submitted on 19 Sep 2023
175 points (100.0% liked)

Socialism

2850 readers
3 users here now

Beehaw's community for socialists, communists, anarchists, and non-authoritarian leftists (this means anti-capitalists) of all stripes. A place for all leftist and labor news and discussion, as long as you're nice about it.


Non-socialists are welcome to come to learn, though it's hard to get to in-depth discussions if the community is constantly fighting over the basics. We ask that non-socialists please be respectful and try not to turn this into a "left vs right" debate forum by asking leading questions or by trying to draw others into a fight.


This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] theodewere@kbin.social 9 points 1 year ago* (last edited 1 year ago)

any chode who argues that drug prices need to be high to fund research is just a chode being a chode

the Biden administration announced the list of ten drugs over whose price Medicare would, for the first time, negotiate, under new authority granted by the Inflation Reduction Act last year

this is huge news that the drug companies hate

Big Pharma, unsurprisingly, is fighting against the Biden administration’s efforts, launching lawsuits to block the new rules. Meanwhile, writers at the Economist — also unsurprisingly — have come to the aid of Big Pharma in its hour of need. While conceding that Americans do spend too much on drugs, the “newspaper” nonetheless complains that the new “heavy handed” rules “have swung from one extreme to the other.”

and their friends are trying to help them, showing just how reactionary they are to anything that helps patients, by calling negotiation "extreme".. free market is just too scary for these guys i guess..

naturally Big Pharma hopes to get their lawsuits straight onto the Supreme Court docket, where their friends will issue a ruling written by Pfizer